WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
|
|
|
- Oswald Hudson
- 6 years ago
- Views:
Transcription
1 WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded Tumors coded as benign (BEN=3) by the Swedish cancer register have been treated as not recorded Given the selections above only the 1st primary have been considered Only the 1st primary cases diagnosed after cohort enrollment and up to 31-Dec-211 are included in the tabulations below A 1st primary before enrollment censor the woman from further cancer events Information about emigration or death or other data sources have not been utilized Note: This presentation is intended for planning purposes only. Note: This is an update of the SAS program created earlier for data up to 31-Dec-2012 Pouran Almstedt, MEB - Karolinska Institutet 1/6 August 2014
2 WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 Malign 1st primary tumors after cohort enrollment up to 31Dec digit codes =191 (non-melanoma skin cancer) not considered Percent of -3 digits Frequency Total codes Count Frequency 170 Breast Malignant melanoma of skin Bronchus and trachea, and lung specified as primary Corpus uteri Ovary, Fallopian tube and broad ligament Brain and other parts of nervous system Large intestine, except rectum Rectum Other endocrine glands Other and unspecified sites Cervix uteri Lymph sarcoma and reticulosarcoma Kidney Bladder and other urinary organs Pancreas Thyroid gland Multiple myeloma (plasmocytoma) Stomach Biliary passages and of liver Acute chronic and lymphoblastic leukaemia Mycosis fungoides Connective tissue Uterus, unspecified Other and unspecified female genital organs Tongue Small intestine, including duodenum Hodgkin disease Other parts of mouth Oral mesopharynx Polycytemia vera Other, unspecified chronic myeloproliferative disease Oesophagus Pouran Almstedt, MEB - Karolinska Institutet 2/6 August 2014
3 Percent of -3 digits Frequency Total codes Count Frequency 202 Other forms of lymphoma (reticulosis) Haematopoietic system Malignant neoplasm of salivary gland Malignant neoplasm of bone (including jaw bone) Nose, nasal cavities, middle ear Lymphatic system Malignant neoplasm of floor of mouth Malignant neoplasm of nasopharynx Lip Malignant neoplasm of peritoneum Malignant neoplasm of larynx Malignant neoplasm of mediastinum Malignant neoplasm of other parts of uterus ===== ====== Pouran Almstedt, MEB - Karolinska Institutet 3/6 August 2014
4 Malign 1st primary tumors after cohort enrollment up to 31Dec2012-4digit codes Benign =171 (Cervix uteri) or =191 (non-melanoma skin cancer) not considered Malignant neoplasm of breast (left) Malignant neoplasm of breast (right) Malignant neoplasm of bronchus and lung Malignant neoplasm of ovary Cerebral meninges/malignant neoplasm of brain Malignant melanoma of lower limb, including hip Malignant neoplasm of rectosigmoid junction Lymph nodes of head, face and neck/lymph node, unspecified Secondary malignant neoplasm of liver Breast, unspecified Bålen, axill, ljumske, scapulareg, perineum Parathyroid gland Follicular/unspecified and other types of follicular NHL, unspecific T-cell/B-cell lymphoma. Sigmoid colon Overlapping lesion of breast Malignant neoplasm of bladder Malignant melanoma of upper limb, including shoulder Malignant neoplasm of colon (Caecum/Ascending colon) Malignant neoplasm of kidney (Unspecified) Malignant neoplasm of kidney, except renal pelvis Malignant melanoma of skin, unspecified Acute myeloid leukaemia Stomach, unspecified Chronic lymphocytic leukaemia Pituitary gland Liver cell carcinoma/intrahepatic bile duct carcinoma Malignant neoplasm of colon (Hepatic or Splenic flexure Colon, unspecified Appendix Anus, unspecified Spinal meninges/cerebral meninges Malignant neoplasm of colon (Descending colon) Pouran Almstedt, MEB - Karolinska Institutet 4/6 August 2014
5 Malign 1st primary tumors after cohort enrollment up to 31Dec2012-4digit codes Benign =171 (Cervix uteri) or =191 (non-melanoma skin cancer) not considered Central nervous system, unspecified/meninges, UNS Malignant neoplasm of gallbladder Abdomen/Ill-defined sites within the digestive system Cardia Malignant neoplasm of adrenal gland (Cortex/Medulla/Unspec Vulva, unspecified Connective and soft tissue of lower limb, including hip Tonsil, unspecified (Nos, faucial, palatine Body of stomach, Pyloric antrum Overlapping lesion of female genital organs Malignant neoplasm of breast (unknown side) Connective and soft tissue of thorax/abdomen/pelvix Malignant melanoma of scalp and neck Chronic myeloid leukaemia Malignant neoplasm of vagina Malignant neoplasm of small intestine; Jejunum/Ileum Labium majus/labium minus Malignant neoplasm of renal pelvis Malignant neoplasm of base of tongue Small intestine; unspecified Extrahepatic bile duct Malignant melanoma of other and unspecified parts of face Malignant neoplasm of eye and adnexa, eyball/ciliary body Non-Hodgkin's lymphoma, unspecified type Malignant mast cell tumour, Peripheral T-cell lymphoma, Malignant- neoplasm without specification Acute lymphoblastic leukaemia Essential (haemorrhagic) thrombocythaemia Border of tongue Tongue, unspecified Middle third of oesophagus Oesophagus, unspecified Acute monocytic leukaemia External lower lip (nos, lipstick area, vermilion border) Pouran Almstedt, MEB - Karolinska Institutet 5/6 August 2014
6 Malign 1st primary tumors after cohort enrollment up to 31Dec digit codes Benign =171 (Cervix uteri) or =191 (non-melanoma skin cancer) not considered Malignant neoplasm of parotid gland Major salivary gland (major) Nos Biliary tract, unspecified Pleura Malignant melanoma of ear and external auricular canal Endocrine pancreas Malignant neoplasm of bone (including jaw bone) - Lower limb, long bones Connective and soft tissue of trunk, unspecified Connective and soft tissue of upper limb,including shoulder Retroperitoneal rum Connective and soft tissue, unspecified Acute promyelocytic leukaemia, Acute myelomonocytic leuk Submandibular gland Malignant neoplasm of small intestine, including duodenum Duodenum Nasal cavity Malignant neoplasm of nasal cavity Malignant neoplasm of Middle ear Etmoidalsinus (Ethmoid holes) Nose s sinus paranasales unspecified Female genital organ, unspecified Urethra Overlapping malignant melanoma of skin Malignant neoplasm of eye Carotid body Mandible Malignant neoplasm of bone (including jaw bone) - Bones of the skull and face Connective and soft tissue of head, face and neck Malignant neoplasm of other and unspecified sites Malignant neoplasm of Pelvix Lymphosarcoma and reticulosarcoma Hairy-cell leukaemia Pouran Almstedt, MEB - Karolinska Institutet 6/6 August 2014
7 Malign 1st primary tumors after cohort enrollment up to 31Dec2012-4digit codes Benign =171 (Cervix uteri) or =191 (non-melanoma skin cancer) not considered Other lymphoid leukaemia Acute leukaemia of unspecified cell type ===== ===== Sum: Pouran Almstedt, MEB - Karolinska Institutet 7/6 August 2014
WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded
Cancer Association of South Africa (CANSA)
Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)
Cancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
ANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
APPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
S2 File. Clinical Classifications Software (CCS). The CCS is a
S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous
82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung
82330 CALCIUM; IONIZED ICD-10 Codes that Support Medical Necessity ICD-10 Code Description A15.0 Tuberculosis of lung A15.4 Tuberculosis of intrathoracic lymph nodes A15.5 Tuberculosis of larynx, trachea
155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary
ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant
2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill
Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional
Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.
Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and
incidence rate x 100,000/year
Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European
Florida Cancer Data System STAT File Documentation Version 2019
Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status
All Discovered Death Outcome Detail (Form 124/120)
This file includes all reported deaths regardless of consent. ID WHI Common ID Col#1 DEATHALL All Discovered Death Col#2 Any report of death, regardless of consent status. 0 No 106,931 66.1 1 Yes 54,877
CEA (CARCINOEMBRYONIC ANTIGEN)
(CARCINOEMBRYONIC ANTIGEN) 428 C15.3 Malignant neoplasm of upper third of esophagus C15.4 Malignant neoplasm of middle third of esophagus C15.5 Malignant neoplasm of lower third of esophagus C15.8 Malignant
2016 Cancer Registry Annual Report
2016 Cancer Registry Annual Report Cancer Committee Chairman s Report The Cancer Committee at Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center (Eastern), established in 2006,
Cancer survival in Shanghai, China,
Cancer survival in Shanghai, China, 1992 1995 Xiang YB, Jin F and Gao YT Abstract The Shanghai cancer registry, established in 1963, is the oldest one in mainland China; cancer registration is entirely
*
Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The
DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY
Date: 10 th April 2018 DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY Request: 1. Utilization Data of Overseas Beam Therapy and Brachytherapy 2. Diagnoses Data of Overseas Claims for Beam Therapy and Brachytherapy
Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute
Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute Paul R. Yarnold, Ph.D. and Robert C. Soltysik, M.S. Optimal Data Analysis, LLC Imagine a random sample
MALIGNANT NEOPLASMS OF THE BREAST MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS
MALIGNANT NEOPLASMS OF THE (INC. PAGET S DISEASE) 0 - Nipple and areola 1 - Central portion 2 - Upper-inner quadrant 3 - Lower-inner quadrant 4 - Upper-outer quadrant 5 - Lower-outer quadrant 6 - Axillary
Cancer Incidence in Sweden 1998
STATISTICS HEALTH AND DISEASES 2000:4 Cancer Incidence in Sweden 1998 CENTRE FOR EPIDEMIOLOGY SVERIGES OFFICIELLA STATISTIK OFFICIAL STATISTICS OF SWEDEN Statistics - Health and Diseases Cancer Incidence
John R. Marsh Cancer Center
John R. Marsh Cancer Center Lung Program Overview: 2014-2015 Initiatives Lung CT Screening Dr. Gregory Zimmerman In cooperation with The Lung Cancer Steering Committee, Diagnostic Imaging Services at the
Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green
Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green Digestive system 1. Teeth Main points: external and internal structure of a tooth, fixation of a tooth
BRAF Mutation Analysis
Last Review Date: October 13, 2017 Number: MG.MM.LA.38aC Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
ICD-10 and Radiation Oncology
ICD-10 and Radiation Oncology Steven M. Verno, CEMCS ICD-10 and Radiation Oncology Steven M. Verno, CEMCS September 23, 2008 Note: ICD-9-CM and ICD-10 are owned and copyrighted by the World Health Organization.
Clinical Coding for CRS Standards
Clinical Coding for CRS Standards The following appendices set out the amended PRIMARY DIAGNOSIS coding structure to be used for the monitoring of cancer waiting times following the implementation of 4th
Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths
RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected
Cancer survival in Hong Kong SAR, China,
Chapter 5 Cancer survival in Hong Kong SAR, China, 1996 2001 Law SC and Mang OW Abstract The Hong Kong cancer registry was established in 1963, and cancer registration is done by passive and active methods.
END-SEMESTER EXAM 2018 ANATOMY, HISTOLOGY AND EMBRYOLOGY FACULTY OF MEDICINE, 2 ND SEMESTER
University of Szeged, Faculty of Medicine Department of Anatomy, Histology and Embryology Chairman: Prof. Antal Nógrádi MD, PhD, DSc Kossuth L. sgt. 40., H-6724 Szeged, Hungary Tel.: +36-62-545-665 P.
Cancer survival in Seoul, Republic of Korea,
Cancer survival in Seoul, Republic of Korea, 1993 1997 Ahn YO and Shin MH Abstract The Seoul cancer registry was established in 1991. Cancer is a notifiable disease, and registration of cases is done by
Chapter II: Overview
: Overview Chapter II: Overview This chapter provides an overview of the status of cancer in Minnesota, using cases reported to the Minnesota Cancer Surveillance System (MCSS) and deaths reported to the
American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013
American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 All ages Younger than 45 45 and Older Younger than 65 65 and Older All sites, men 306,920 9,370 297,550 95,980 210,940 All sites,
Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018)
Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018) Please refer to your standard setter(s) for specific reporting requirements before using
Model Policy. Coverage of Proton Therapy
Model Policy Coverage of Proton Therapy Last Revised - February 2019 INTRODUCTION Proton therapy is a technologically advanced method to deliver curative radiation doses to cancerous tumors. The unique
2012 Cancer Report 2011 Registry Data
2012 Cancer Report 2011 Registry Data Contents Goals and Objectives 1 2012 Cancer Committee Members 2 Total Cancer Cases 1981-2011 3 Cancer Registry Frequency Report 1981-2011 4-5 Cancer Registry Frequency
SCCA REFERENCE MANUAL ICD-10
SCCA REFERENCE MANUAL ICD-10 NORTHWEST HOSPITAL 1 BREAST CANCER BREAST (INC. PAGET S DISEASE) 0 - Nipple and areola 1 - Central portion 2 - Upper-inner quadrant 3 - Lower-inner quadrant 4 - Upper-outer
Serum Iron Studies
190.18 - Serum Iron Studies Serum iron studies are useful in the evaluation of disorders of iron metabolism, particularly iron deficiency and iron excess. Iron studies are best performed when the patient
Anatomical Considerations for Lab Practical II
Anatomical Considerations for Lab Practical II For each of the following please be prepared to provide: Identification System Organ(s) or ducts to Function(s) location which it is attached Use your lecture
Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER
Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER Table 1.1 gives the total number of cancers diagnosed at five different hospital based cancer registries (HBCRs), over the period of two years from 1st January
National Cancer Patient Experience Survey 2016 Technical Documentation July 2017
National Cancer Patient Experience Survey 2016 Technical Documentation July 2017 1 Contents 1. Introduction 2. Scoring 3. Significance Tests (for national data) 4. Case-mix Adjustment (for local data)
Contractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416)
Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor
A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files
A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files By Dr. Martin A. Whiteside Director, Office of Cancer
CHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster
CHAPTER 10 CANCER REPORT Jeremy Chapman and Angela Webster CANCER REPORT ANZDATA Registry 2004 Report This report summarises the cancer (excluding nonmelanocytic skin cancer) experience of patients treated
CLINICAL MEDICATION POLICY
Policy Name: Policy Number: Approved By: CLINICAL MEDICATION POLICY Keytruda (pembrolizumab) MP-014-MD-DE Medical Management; Clinical Pharmacy Provider Notice Date: 01/15/2018; 08/01/2017; 06/01/2016
Republican Research and Practical Center for Radiation Medicine and Human Ecology. Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus
Republican Research and Practical Center for Radiation Medicine and Human Ecology Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus The contaminated area in the Republic of Belarus consisted
CLINICAL MEDICATION POLICY
Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICATION POLICY Granulocyte Colony Stimulating Factors (G-CSFs) MP-016-MD-DE Medical Management; Clinical Pharmacy Provider Notice Date:
Neoplasms/Lymphoma/Leukemia
Neoplasms/Lymphoma/Leukemia Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and
Cancer Treatment Centers of America ATLANTA CANCER REGISTRY. Annual Report
Cancer Treatment Centers of America ATLANTA CANCER REGISTRY Annual Report CANCER COMMITTEE Chairman s Report On behalf of the Cancer Committee a multidisciplinary team of boardcertified physicians and
Cancer in Utah: An Overview of Cancer Incidence and Mortality from
Cancer in Utah: An Overview of Cancer Incidence and Mortality from 1973-2010 A publication of the Utah Cancer Registry January 2014 Prepared by: C. Janna Harrell, MS Senior Research Analyst Kimberly A.
Cancer Program Report 2014
Cancer Program Report 2014 Queen of the Valley Hospital St Joseph Health Queen of the Valley Hospital - 2014 Site Table Site Total Class Sex Group Cases Analytic NonAn M F 0 I II ALL SITES 661 494 167
CODING PRIMARY SITE. Nadya Dimitrova
CODING PRIMARY SITE Nadya Dimitrova OUTLINE What is coding and why do we need it? ICD-10 and ICD-O ICD-O-3 Topography coding rules ICD-O-3 online WHAT IS CODING AND WHY DO WE NEED IT? Coding: to assign
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999 Menzies Centre for Population Health Research University of Tasmania Tasmanian Cancer Registry 17 Liverpool
Table S1. International classification of disease (ICD)-9 codes and descriptions of malignancy. types. Additional file 1
Additional file 1 Table S1. International classification of disease (ICD)-9 codes and descriptions of malignancy types. Malignancy Type ICD-9 Description Bone & Soft-tissue 170.0-170.9 Malignant neoplasm
CLINICAL MEDICATION POLICY
CLINICAL MEDICATION POLICY Policy Name: Opdivo (nivolumab) injection Policy Number: Approved By: Medical Management, Clinical Pharmacy Products: Highmark Health Options Application: All participating hospitals
Information Services Division NHS National Services Scotland
Cancer in Scotland October 2012 First published in June 2004, revised with each National Statistics publication Next due for revision April 2013 Information Services Division NHS National Services Scotland
Research Article Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program
Hindawi Publishing Corporation Journal of Cancer Epidemiology Volume 2014, Article ID 437971, 18 pages http://dx.doi.org/10.1155/2014/437971 Research Article Cancer Incidence in Egypt: Results of the National
Appendix A: Definitions for Cancer Incidence Data
Appendices Cancer in Minnesota, 1988-2002 231 Appendix A: Definitions for Cancer Incidence Data MCSS collects information on all microscopically confirmed malignant and in situ tumors diagnosed in Minnesota
Introduction to ICD-O-3 coding rules
Introduction to ICD-O-3 coding rules Weena Laddachayaporn, MD National Cancer Institute, Bangkok, Thailand ICD-O-3 The International Classification of Diseases for Oncology Is a coding system for primary
SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl
SEER Advanced Topic 2018 Presentation EOD 2018 and SS2018 Jennifer Ruhl May 25, 2018 Outline General overview of EOD Schemas Basic review of what is needed to collect Primary Tumor, Regional Nodes and
Comprehensive cancer cover
Retirement Investments Insurance Health Comprehensive cancer cover Life Insurance+ with critical illness and Critical Illness+ Cancer is one of the biggest fears for the British public This is why our
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind
Carcinoembryonic Antigen
Other Names/Abbreviations CEA 190.26 - Carcinoembryonic Antigen Carcinoembryonic antigen (CEA) is a protein polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring
Peripheral Nerve Blocks
Last Review Date: April 21, 2017 Number: MG.MM.ME.64v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
Cancer survival in Busan, Republic of Korea,
Cancer survival in Busan, Republic of Korea, 1996 2001 Shin HR, Lee DH, Lee SY, Lee JT, Park HK, Rha SH, Whang IK, Jung KW, Won YJ and Kong HJ Abstract The Busan cancer registry was established in 1996;
Comprehensive cancer cover
Retirement Investments Insurance Health Comprehensive cancer cover Life Insurance+ with critical illness and Critical Illness+ Cancer is one of the biggest fears for the British public This is why our
Cancer in Central and South America BOLIVIA
Cancer in Central and South America BOLIVIA This country profile for the Cancer in Central and South America project provides, for each participating cancer registry tables and graphics showing numbers
SHN-1 Human Digestive Panel Test results
SHN-1 Human Digestive Panel Test results HN-30 tongue HN-24 salivary gland HN-12 larynx HN-28 esophagus HN-29 stomach HN-20 pancreas HN-13 liver HN-14 gall bladder HN-27-1 duodenum HN-27-2 ileum HN-27-3
Cancer in Colorado Incidence, Mortality, and Survival
Cancer in Colorado 1998-2003 Incidence, Mortality, and Survival Jack L. Finch, M.S. Statistical Analyst III Kieu O. Vu, M.S.P.H. Statistical Analyst II 2007 Colorado Central Cancer Registry Randi K. Rycroft,
CLIC Sargent Eligibility Criteria
1 Eligibility Criteria DOCUMENT GOVERNANCE: Eligibility criteria Produced by J. Hawkins & Grants Team Sponsored by Dara de Burca Version Approval by Executive Team 10 th June 2014 Board of Trustees 3 rd
Information Services Division NHS National Services Scotland
Cancer in Scotland April 2013 First published in June 2004, revised with each National Statistics publication Next due for revision October 2013 Information Services Division NHS National Services Scotland
2014 CANCER CENTER ANNUAL REPORT
2014 CANCER CENTER ANNUAL REPORT Chairman s Report By Ivan Peacock, MD Ivan Peacock, MD Cancer Committee Chairman I am especially pleased this year to present the Annual Report of the Nash-UNC Comprehensive
LCD for Interferon (L29202)
LCD for Interferon (L29202) Contractor Name First Coast Service Options, Inc. Contractor Number 09102 Contractor Type MAC - Part B Contractor Information LCD ID Number L29202 LCD Information LCD Title
REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after
REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after The following lists are intended to assist you, as the reporter, in identifying the reportable neoplasms for your facility. Any reportable
SKCC Protocol Review Committee New Study Application
Instructions: Submit the following documents to prc@jefferson.edu - Completed New Study Application (aka MCSF) - Protocol - Protocol Facilitation Committee Approval (if applicable) - MDG Priority Score
Cancer Incidence in New Jersey Implementation of the Year 2000 Population Standard
Cancer Incidence in New Jersey 1995-1999 Implementation of the Year 2000 Population Standard Prepared by: Stasia S. Burger, MS, CTR Judith B. Klotz, MS, DrPH Rachel Weinstein, MS, PhD Toshi Abe, MSW, CTR
Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15
1 1500 MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS 1 1501 MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS 1 1502 MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS 1 1503 MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS 1
Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005
ChecklistTemplateVersions ChecklistTemplateVersion Ckey OfficialName VisibleText RevisionDate Checklist; Adrenal gland: 16.1000043 Resection Adrenal gland: Checklist; Ampulla of 17.1000043 Vater: Ampullectomy
Subject Cancers in Firefighters and Fire Investigators
If a firefighter or a fire investigator is diagnosed with a prescribed on or after January 1, 1960, and meets the employment duration and additional criteria for the prescribed, then the disease is presumed
Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies
Web appendix 2: SEARCH STRATEGIES Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies MEDLINE 1. exp epidemiologic studies/
Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information
Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor
Cancer in Norway Cancer incidence, mortality, survival and prevalence in Norway
Cancer in Norway 7 Cancer incidence, mortality, survival and prevalence in Norway Special issue: Long-term cancer survival: patterns and trends in Norway 96-7 Cancer in Norway 7 Editor-in-chief: Freddie
This lab activity is aligned with Visible Body s Human Anatomy Atlas app. Learn more at visiblebody.com/professors
1 This lab activity is aligned with Visible Body s Human Anatomy Atlas app. Learn more at visiblebody.com/professors 2 A. Digestive System Overview To Start: Go to the Views menu and scroll down to the
Cancer in Norway Cancer incidence, mortality, survival and prevalence in Norway
Cancer in Norway 2007 Cancer incidence, mortality, survival and prevalence in Norway Special issue: Long-term cancer survival: patterns and trends in Norway 1965-2007 Cancer in Norway 2007 Editor-in-chief:
Gamma Glutamyl Transferase
Other Names/Abbreviations GGT 190.32 - Gamma Glutamyl Transferase Gamma glutamyl transferase (GGT) is an intracellular enzyme that appears in blood following leakage from cells. Renal tubules, liver, and
CANCER REGISTRY Annual Report
CANCER REGISTRY Annual Report 2017 Cancer Treatment Centers of America at Southeastern Regional Medical Center Atlanta, Georgia Philadelphia, Pennsylvania Chicago, Illinois Tulsa, Oklahoma Phoenix, Arizona
Genetic Testing for Cancer Susceptibility
Last Review Date: March 10, 2017 Number: MG.MM.AD.17v3 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
Cancer in Norway Cancer incidence, mortality, survival and prevalence in Norway
Cancer in Norway 217 Cancer incidence, mortality, survival and prevalence in Norway Cancer in Norway 217 Cancer in Norway 217 Editor-in-chief: Inger Kristin Larsen Editorial team: IK Larsen, B Møller,
Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information
Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor
Key Words. Cancer statistics Incidence Lifetime risk Multiple primaries Survival SEER
The Oncologist Epidemiology and Population Studies: SEER Series Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program MATTHEW
Outcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.
OVARIES URETER FALLOPIAN TUBES BLADDER UROGENITAL OPENINGS (BOTH SEXES) PENIS VAGINA UTERUS
URETER OVARIES FALLOPIAN TUBES BLADDER UROGENITAL OPENINGS (BOTH SEXES) PENIS VAGINA UTERUS REPRODUCTIVE PRODUCE FEMALE HORMONES EXCRETORY FROM KIDNEY TO BLADDER EXCRETORY STORES URINE REPRODUCTIVE TRANSPORTS
Date Lab Pd. Lecture Notes (57)
Name SECTION OBJECTIVES Describe the locations of the major body cavities List the organs located in each major body cavity Name the membranes associated with the thoracic and abdominopelvic cavities Name
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 Menzies Centre For Population Health Research Editors: Dace Shugg, Terence Dwyer and Leigh Blizzard Publication
Colony Stimulating Factors: Neupogen (filgrastim), Neulasta (pegfilgrastim), Leukine (sargramostim), Granix (tbo-filgrastim)
Neupogen (filgrastim), Neulasta (sargramostim), Granix (tbo-filgrastim) Date of Origin: 10/17/2008 Dates Reviewed: 6/17/2009, 12/22/2009, 06/15/2010/ 7/20/2010, 09/2010, 12/2010, 03/2011, 06/2011, 09/2011,
Intensity Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) [For the list of services and procedures that need preauthorization, please refer to www.mcs.com.pr go to Comunicados a Proveedores, and click Cartas Circulares.]
Cancer in New Mexico 2017
Cancer in New Mexico 0 Please contact us! Phone: 0-- E-Mail: nmtr-info@salud.unm.edu URL: nmtrweb.unm.edu TABLE OF CONTENTS Introduction... New Cases of Cancer Estimated Number of New Cancer Cases Description
AMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING
AMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING ATLAS EDITORS FREDERICK L. GREENE, m.d. Chair, Department of General Surgery Carolinas Medical Center Charlotte, North Carolina CAROLYN C. COMPTON,
Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004
MCSS Epidemiology Report 04:2 Suggested citation Perkins C, Bushhouse S.. Minnesota Cancer Surveillance System. Minneapolis, MN, http://www.health.state.mn.us/divs/hpcd/ cdee/mcss),. 1 Background Cancer
Table of Contents. Last updated by CLO: 5/8/2013 1
Table of Contents Drug-induced liver injury algorithm - Cases... 2 Drug-induced liver injury algorithm - Controls... 3 1. Summary of drug-induced liver injury algorithm... 4 2. Terminology... 4 3. Threshold